TrialBMC cancer2022

Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial.

Anthony B El-Khoueiry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.